Get started
Author

Dennis Williams

Observed name: D. Williams
OpenAlex ID: A5032561789
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
2024 · Sandra P D'Angelo, Dejka M Araujo, et al. · The Lancet · 304
PDF
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial
2023 · David S. Hong, Brian A. Van Tine, et al. · Nature Medicine · 205
PDF
Phase I dose escalation and expansion trial to assess the safety and efficacy of ADP-A2M4 SPEAR T cells in advanced solid tumors.
2020 · David S. Hong, Brian A. Van Tine, et al. · Journal of Clinical Oncology · 51
SPEARHEAD-1: A phase 2 trial of afamitresgene autoleucel (Formerly ADP-A2M4) in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma.
2021 · Sandra P. D'Angelo, Brian Andrew Van Tine, et al. · Journal of Clinical Oncology · 36
Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial.
2024 · Sandra P. D'Angelo, Andrew James Scott Furness, et al. · Journal of Clinical Oncology · 23
PDF
Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients
2024 · Tianjiao Wang, Jean-Marc Navenot, et al. · Molecular Therapy — Methods & Clinical Development · 21
SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma.
2020 · Dejka M. Araujo, Mihaela Druta, et al. · Journal of Clinical Oncology · 10
The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma.
2023 · Brian Andrew Van Tine, Kristen N. Ganjoo, et al. · Journal of Clinical Oncology · 8
A call to adapt the regulation of HLA testing for T cell receptor-based therapeutics
2023 · Miriam Meyer, Andrea Mahr, et al. · Nature Reviews Drug Discovery · 6
Brief Communication on MAGE-A4 and Coexpression of Cancer Testis Antigens in Metastatic Synovial Sarcomas: Considerations for Development of Immunotherapeutics
2024 · Hélène Vanacker, Robert Connacher, et al. · Journal of Immunotherapy · 5
GOG-3084: A phase II trial of ADP-A2M4CD8 TCR-T cell therapy, alone or in combination with nivolumab, among patients with recurrent ovarian cancers
2024 · Kathleen Moore, Ana Oaknin, et al. · Gynecologic Oncology · 2
Impact of a transfusion‐related acute lung injury reduction strategy on apheresis platelet collections
2012 · Dennis Williams, Marepalli Rao, et al. · Journal of Clinical Apheresis · 2
Pooled analyses of clinical outcomes with afamitresgene autoleucel (afami-cel) in metastatic synovial sarcoma.
2026 · Sandra P. D'Angelo, Dejka M. Araujo, et al. · Journal of Clinical Oncology · 1
PDF
320 Integrated efficacy and safety analysis of letetresgene autoleucel, a T-cell receptor T-cell therapy, across clinical trials of patients with synovial sarcoma and myxoid/round cell liposarcoma
2025 · Sandra P D’Angelo, Dejka M Araujo, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Long-Term Survival of Patients with Advanced/Metastatic Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Who Received the T-Cell Receptor T-Cell Therapy, Afamitresgene Autoleucel, in the Phase 2 Spearhead-1 Trial
2025 · Sandra P. D'Angelo, Mihaela Druta, et al. · Transplantation and Cellular Therapy · 1
#24 A phase 2 study (GOG-3084) OF ADP-A2M4CD8 TCR T-cell therapy, alone or in combination with nivolumab, in patients with recurrent ovarian cancers
2023 · Kathleen Moore, A.n.a. Oaknin, et al. · International Journal of Gynecological Cancer · 1
PDF
The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma.
2023 · Sandra P. D'Angelo, Kristen N. Ganjoo, et al. · Journal of Clinical Oncology · 1
Pooled Analysis of Trabectedin Efficacy in Myxoid/Round Cell Liposarcoma from Three Prospective Clinical Trials
2026 · Michael Jason Nathenson, Lucy Hoch, et al. · Cancers
Synovial sarcoma misdiagnosis and potential utility of NGS testing patient identification for autologous T cell therapy: Retrospective analysis of Tempus database.
2026 · Michael Jason Nathenson, Ian Donaldson, et al. · Journal of Clinical Oncology
Efficacy and safety of engineered TCR-T cell therapy (afami-cel, lete-cel) in pediatric synovial sarcoma.
2026 · Amy E. Armstrong, Veronique Minard-Colin, et al. · Journal of Clinical Oncology
Myxoid/round cell liposarcoma misdiagnosis incidence, etiology, and importance of NY-ESO-1 testing: Retrospective analysis of the Tempus database.
2026 · Michael Jason Nathenson, Ian Donaldson, et al. · Journal of Clinical Oncology
Performance status and quality of life in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma receiving afamitresgene autoleucel
2025 · M.J. Wagner, C. Lunt, et al. · ESMO rare cancers.
Works count: 22
Citation count: 677
H-index: 8
I10-index: 7
Year
Topic
Type